Both in Biotechnology
Atara Biotherapeutics vs LENZ Therapeutics
Over the past year ATRA returned −37.8% and LENZ returned −87.3%; their daily moves had a correlation of 0.06.
ATRA −37.8% LENZ −87.3%Growth of $1, one year, split-adjusted
| Metric | ATRA | LENZ |
|---|---|---|
| Price | $8.62 | $3.55 |
| Market cap | $86.5M | $111.5M |
| Today | +1.65% | +16.39% |
| 1 month | −8.3% | −1.1% |
| 6 months | +81.1% | −60.9% |
| Year to date | −52.3% | −77.8% |
| 1 year | −42.0% | −88.1% |
| Revenue growth (YoY) | −96.4% | +9.7% |
| Gross margin | 69.7% | 94.9% |
| Net margin | −767.3% | −581.8% |
| P/E (TTM) | — | — |
| Price / sales | 14.0× | 5.2× |
| Net cash | $9.9M | $220.0M |
| Dividend yield | — | — |
| Volatility (60d) | 65.2% | 77.2% |
| Short % of float | 11.2% | 46.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).